Clinical Trial Update: 18F-FLT-PET in Breast Cancer (MK-0000-139) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating 18F-FLT-PET in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MK-0000-139

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-12-20